Expert Opinion on Investigational Drugs, Volume 30, Issue 1 (2021)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Investigational Drugs, Volume 30, Issue 1 (2021)

See all volumes and issues
Vol 33, 2024 Vol 32, 2023 Vol 31, 2022 Volume 30, 2021 Vol 29, 2020 Vol 28, 2019 Vol 27, 2018 Vol 26, 2017 Vol 25, 2016 Vol 24, 2015 Vol 23, 2014 Vol 22, 2013 Vol 21, 2012 Vol 20, 2011 Vol 19, 2010 Vol 18, 2009 Vol 17, 2008 Vol 16, 2007 Vol 15, 2006 Vol 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994
Download citations Download PDFs Download issue

Editorial

Editorial
Repurposing elesclomol, an investigational drug for the treatment of copper metabolism disorders
Vishal M. Gohil
Pages: 1-4
Published online: 05 Nov 2020
First Page PreviewforRepurposing elesclomol, an investigational drug for the treatment of copper metabolism disorders | Full Text | References | PDF (1.2 MB) | EPUB
  • 4800 Views
  • 19 CrossRef citations
  • 0Altmetric
Free Access

Drug Evaluation

Article
AE37: a HER2-targeted vaccine for the prevention of breast cancer recurrence
Patrick M. McCarthy, G. Travis Clifton, Timothy J. Vreeland, Alexandra M. Adams, Anne E. O’Shea & George E. Peoples
Pages: 5-11
Published online: 03 Dec 2020
AbstractforAE37: a HER2-targeted vaccine for the prevention of breast cancer recurrence | Full Text | References | PDF (888.6 KB) | EPUB
  • 461 Views
  • 15 CrossRef citations
  • 0Altmetric

Review

Translesion synthesis inhibitors as a new class of cancer chemotherapeutics
Seema M. Patel, Radha Charan Dash & M. Kyle Hadden
Pages: 13-24
Published online: 03 Dec 2020
AbstractforTranslesion synthesis inhibitors as a new class of cancer chemotherapeutics | Full Text | References | PDF (3.6 MB) | EPUB
  • 611 Views
  • 15 CrossRef citations
  • 0Altmetric
Investigational drugs for the treatment of diffuse large B-cell lymphoma
Andrea Patriarca & Gianluca Gaidano
Pages: 25-38
Published online: 21 Dec 2020
AbstractforInvestigational drugs for the treatment of diffuse large B-cell lymphoma | Full Text | References | PDF (1.6 MB) | EPUB
  • 4760 Views
  • 20 CrossRef citations
  • 0Altmetric
Open Access

Perspective

Therapeutic considerations for APOE and TOMM40 in Alzheimers disease: A tribute to Allen Roses MD
Marwan Noel Sabbagh, Evans Pope, Laura Cordes, Jiong Shi & Boris DeCourt
Pages: 39-44
Published online: 02 Dec 2020
AbstractforTherapeutic considerations for APOE and TOMM40 in Alzheimers disease: A tribute to Allen Roses MD | Full Text | References | PDF (289.6 KB) | EPUB
  • 191 Views
  • 2 CrossRef citations
  • 0Altmetric

Review

An overview on the use of antivirals for the treatment of patients with COVID19 disease
Maricar Malinis, Dayna McManus, Matthew Davis & Jeffrey Topal
Pages: 45-59
Published online: 15 Dec 2020
AbstractforAn overview on the use of antivirals for the treatment of patients with COVID19 disease | Full Text | References | PDF (2.5 MB) | EPUB
  • 2832 Views
  • 4 CrossRef citations
  • 0Altmetric
Free Access
Recent progress in development of cyclin-dependent kinase 7 inhibitors for cancer therapy
Hanzhi Liang, Jintong Du, Reham M. Elhassan, Xuben Hou & Hao Fang
Pages: 61-76
Published online: 11 Jan 2021
AbstractforRecent progress in development of cyclin-dependent kinase 7 inhibitors for cancer therapy | Full Text | References | PDF (1.5 MB) | EPUB
  • 666 Views
  • 4 CrossRef citations
  • 0Altmetric

Original Research

Article
A Phase I, Randomized, Double-Blind, Single-Dose, Parallel-Group Study to compare Pharmacokinetic Similarity, Safety, and Immunogenicity Between BAT2506 and Golimumab in Healthy Chinese Male Subjects
Min Wu, Jixuan Sun, Dandan Wu, Jia Xu, Jin Wei, Zhaohe Wang, Jinchen Yu, Shengfeng Li, Hong Zhang & Yanhua Ding
Pages: 77-83
Published online: 26 Nov 2020
AbstractforA Phase I, Randomized, Double-Blind, Single-Dose, Parallel-Group Study to compare Pharmacokinetic Similarity, Safety, and Immunogenicity Between BAT2506 and Golimumab in Healthy Chinese Male Subjects | Full Text | References | PDF (1.1 MB) | EPUB
  • 142 Views
  • 1 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Spleen tyrosine kinase (SYK): an emerging target for the assemblage of small molecule antitumor agents
Charanjit Kaur et al.
Review Article | Published online: 3 Aug 2024
Investigational CXCR4 inhibitors in early phase development for the treatment of hematological malignancies
Enrica Antonia Martino et al.
Review Article | Published online: 3 Aug 2024
An overview of conventional and investigational phosphodiesterase 5 inhibitors for treating erectile dysfunction and other conditions
Ezzat A. Ismail et al.
Review Article | Published online: 3 Aug 2024
Investigative agents for atrial fibrillation: agonists and stimulants, progress and expectations
Ruben Casado-Arroyo et al.
Review Article | Published online: 3 Aug 2024
View all latest articles